Login

Library
Shopping Cart
Drug DB
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 

Pharmaceuticals

Drugs for Treating Mental Disorders: Technologies and Global Markets

Bookmark and Share

REPORT HIGHLIGHTS

  • The global mental health pharmaceutical market can be estimated at $80 billion in 2010. This market is expected to increase at a 1.9% compound annual growth rate (CAGR) over the forecast period to reach a value of $88 billion in 2015.
  • The growing elderly population has brought attention to dementia and Alzheimer’s conditions.  This segment has great market potential with a growing need for improved medications and treatment options. The cognitive disorders and dementia sector is valued at $5.5 billion in 2010 and is expected to reach $11 billion by 2015, a 14.9% compound annual growth rate (CAGR).
  • The market for sleep disorders will also experience one of the higher growth rates in this market. This sector represented a $4.5 billion industry in 2010 and is estimated to reach $9 billion by 2015, a 14.9% compound annual growth rate (CAGR).

SUMMARY FIGURE
GLOBAL MENTAL HEALTH PHARMACEUTICAL INDUSTRY BY DRUG CATEGORY, 2009-2015
($ BILLIONS)
Source: BCC Research